Pro MedicusPMDIY +3.45%77 ROC (Joel Greenblatt) % is 535.54% as of Dec. 2025, which is 3% below its 10-year median of 553.23. GuruFocus rates PMDIY with a GF Score™ of 77/100 and a GF Value™ of $39.65 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 668 Healthcare Providers & Services companies, Pro Medicus ranks better than 98.35% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Pro Medicus's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 535.54%.
The historical rank and industry rank for Pro Medicus's ROC (Joel Greenblatt) % or its related term are showing as below:
PMDIY'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 73.76 Med: 553.23 Max: 945.82
Current: 567.73
During the past 13 years, Pro Medicus's highest ROC (Joel Greenblatt) % was 945.82%. The lowest was 73.76%. And the median was 553.23%.
PMDIY's ROC (Joel Greenblatt) % is ranked better than 98.35% of 668
companies
in the Healthcare Providers & Services industry
Industry Median: 12.485
vs PMDIY: 567.73
Pro Medicus's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 11.30% per year.
Pro Medicus (OTCPK:PMDIY) ROC (Joel Greenblatt) % Explanation
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
Pro Medicus ROC (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Pro Medicus's ROC (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PMDIY vs VEEV, BTSG, TEM: ROC (Joel Greenblatt) % Comparison
For the Health Information Services subindustry, Pro Medicus's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pro Medicus ROC (Joel Greenblatt) % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Pro Medicus's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Pro Medicus's ROC (Joel Greenblatt) % falls into.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 535.54% mean?
Pro Medicus (PMDIY) has a ROC (Joel Greenblatt) % of 535.54% as of Dec. 2025. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Pro Medicus and its competitors. This is near median its historical median of 553.23. Over the past decade, Pro Medicus' ROC (Joel Greenblatt) % has ranged from 73.76 to 945.82. According to the industry distribution chart, Pro Medicus ranks #11 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 1.6%.
Is Pro Medicus' ROC (Joel Greenblatt) % too high?
Pro Medicus' current ROC (Joel Greenblatt) % of 535.54% is near median its 10-year median of 553.23. Over the past 10 years, this metric has ranged from a low of 73.76 to a high of 945.82. The Healthcare Providers & Services industry median ROC (Joel Greenblatt) % is 12.49. Pro Medicus' value of 535.54% is 4189.5% above this industry median. Based on the distribution chart, Pro Medicus ranks #11 out of 668 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Pro Medicus has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Pro Medicus' ROC (Joel Greenblatt) % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Pro Medicus ranks #11 out of 668 companies for ROC (Joel Greenblatt) %. This places Pro Medicus in the top 2% of its industry — outperforming the majority of peers. The industry median ROC (Joel Greenblatt) % is 12.49. Pro Medicus' value of 535.54% is 4189.5% above this benchmark. Historically, Pro Medicus' own ROC (Joel Greenblatt) % has ranged from 73.76 to 945.82 over the past decade. While the company's 10-year median is 553.23 vs. the industry median of 12.49, Pro Medicus has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Healthcare Providers & Services company?
The median ROC (Joel Greenblatt) % among Healthcare Providers & Services companies is 12.49, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pro Medicus's current ROC (Joel Greenblatt) % of 535.54% is 4189.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Pro Medicus and its competitors. For the Healthcare Providers & Services industry, the median ROC (Joel Greenblatt) % is 12.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pro Medicus's current ROC (Joel Greenblatt) % is 535.54%, which is near median its own 10-year median of 553.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pro Medicus stock overvalued right now?
Based on GuruFocus' analysis, Pro Medicus (PMDIY) is currently considered Modestly Undervalued. The stock's GF Value™ is $39.65, compared to a current price of $30.00 — trading 24.3% below its estimated fair value. The current ROC (Joel Greenblatt) % is 535.54%, which is near median its 10-year median of 553.23 and 4189.5% above the Healthcare Providers & Services industry median of 12.49. Pro Medicus' overall GF Score™ is 77/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Pro Medicus (PMDIY), the current ROC (Joel Greenblatt) % is 535.54% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pro Medicus (PMDIY) Overvalued in 2026?
Based on GuruFocus' analysis, Pro Medicus stock appears to be undervalued.
The current stock price of $30.00 is trading 24.3% below its estimated GF Value™ of $39.65.
GuruFocus considers Pro Medicus to be Modestly Undervalued.
Key valuation signals for PMDIY:
ROC (Joel Greenblatt) %: 535.54% (near median its 10-year median of 553.23)
GF Value™: $39.65 vs. price of $30.00 (24.3% below fair value)
Industry Position: 4189.5% above the Healthcare Providers & Services median (#11 of 668)
No single metric tells the full story. See the PMDIY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pro Medicus is a healthcare IT company specializing in radiology imaging software. Its main product, Visage 7, is a clinical desktop application that radiologists use to view, enhance, and manipulate images from any device and make a diagnosis. Its main customers are US private academic hospitals. In fiscal 2025, Pro Medicus earned 90% of revenue in North America, 8% from Australia, and the remaining 2% in Europe.
77GF Score
Get the complete analysis for PMDIY
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PMDIY has been successfully added to your 
